EVOMELA (Spectrum Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the EVOMELA drug offered from Spectrum Pharmaceuticals, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Spectrum Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Melphalan |
| SUBSTANCE NAME: | MELPHALAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-03-31 |
| END MARKETING DATE: | 0000-00-00 |
EVOMELA HUMAN PRESCRIPTION DRUG Details:
| Item Description | EVOMELA from Spectrum Pharmaceuticals, Inc. |
| LABELER NAME: | Spectrum Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/10mL) |
| START MARKETING DATE: | 2016-03-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68152-109_5d7cc99a-4fec-4e63-a8b4-86e2d8d6ceb4 |
| PRODUCT NDC: | 68152-109 |
| APPLICATION NUMBER: | NDA207155 |
Other MELPHALAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
